Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
02/2010
02/11/2010US20100035891 Pharmaceutically Active Compounds
02/11/2010CA2732932A1 Organic compounds
02/11/2010CA2732045A1 Urea derivatives as antibacterial agents
02/10/2010EP2151434A1 Alkoxypyrazoles and the process for their preparation
02/10/2010EP2151433A1 Alkoxypyrazoles and the process for their preparation
02/10/2010EP2150536A1 Process for the production of pyrazoles
02/10/2010EP2150535A2 Pyrazole derivatives as p2x7 modulators
02/10/2010EP2150532A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
02/10/2010EP1747196B1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/10/2010EP1525191B1 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives
02/10/2010CN101646654A Indozalyl sulphonamide derivatives useful as glucocorticoid modulators
02/10/2010CN101646653A Fused ring compounds as partial agonists of ppar-gamma
02/10/2010CN101643448A Luminescent compounds containing 3(5)-(9-anthryl) pyrazole group and preparation methods thereof
02/09/2010US7659426 for proliferative, inflammatory diseases and an encephalopathy; non-steroidal anti-inflammatory drugs (NSAIDs); KSRP (KH-type splicing regulatory protein),
02/09/2010US7659408 Especially in which the amide nitrogen is substituted with an adamantyl group, e.g., N-adamantyl-4-chloro-5-(o-fluorophenyl)-1-methyl-3-pyrazolecarboxamide; treating hyperglycemia, diabetes or insulin resistance
02/09/2010US7659307 Heterocyclic carboxamides and their use as fungicides
02/09/2010US7659298 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethylsulphanyl)-N-quinolin-3-ylbenzamide; 2-(3-Phenyl-5-chloro-1-methyl-1H-pyrazol-4-ylmethoxy)-N-naphthalin-2-ylbenzamide; obesity, including obesity of the non-insuline-dependent diabetes patients, sleeping disorders, stroke, nausea and vomiting
02/09/2010US7659297 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines
02/09/2010US7659288 5-aminoalkylpyrazole derivatives as pesticidal agents
02/09/2010CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
02/09/2010CA2291065C Raf kinase inhibitors
02/09/2010CA2192092C Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
02/04/2010WO2010012797A2 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives
02/04/2010WO2010012795A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
02/04/2010WO2010012794A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives
02/04/2010WO2010012442A2 Insecticidal benzenedicarboxamide derivative
02/04/2010WO2009127718A3 Novel microbiocides
02/04/2010US20100029951 Process for producing acrylonitrile compound
02/04/2010US20100029950 Novel substituted 1h-dihydropyrazoles, their preparation and use
02/04/2010US20100029919 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
02/04/2010US20100029612 2-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands
02/04/2010US20100029478 Anthranilic acid diamide derivative with hetero-aromatic and hetero-cyclic substituents
02/04/2010CA2731200A1 Fungicidal n-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
02/04/2010CA2731198A1 Fungicide n-cycloalkyl-n-biphenylmethyl-carboxamide derivatives
02/04/2010CA2729969A1 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives
02/03/2010EP2148865A1 Pyrazole inhibitors of wnt signaling
02/03/2010CN101641334A Oxidative color-developing compounds, salts thereof, process for production of the same, reagent compositions and test tools made by using the same
02/03/2010CN101641333A Amorphous solid composition containing a pyrazole-3-carboxamide in amorphous form and stabilising carriers
02/03/2010CN100586934C Process for the preparation of trifluoromethylthioether
02/02/2010US7655808 Leptomycin B; antiproliferative agents; antitumor agents; antcarcinogenic agents; inhibiting the export of a protein from the nucleus of a cell via a CRM1-mediated process; tissue-targeted therapy; cancer of human breast, lung, ovaries, prostate, and bladder, and leukemia cell
02/02/2010US7655802 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
02/02/2010US7655685 Cardiometabolic disorders like obesity, diabetes, hypertension and dyslipidemias, 3, 4-diarylpyrazole derivatives; highly selective; limited or no CNS adverse side effects, including mood disorders
02/02/2010US7655684 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
02/02/2010US7655683 Imidazolopyrazole derivatives useful as selective androgen receptor modulators
02/02/2010US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands
02/02/2010US7655641 3-(4-{2-[(5-Fluoro-3- methyl-benzo[b]thiophene-2- sulfonyl)-propyl- amino]-ethylsulfanyl}- 2-methyl-phenyl)- propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, hypertension, arteriosclerosis and cardiovascular diseases
02/02/2010CA2401832C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
01/2010
01/28/2010WO2010011570A1 Adamantyl diamide derivatives and uses of same
01/28/2010WO2010009508A1 Antiparasitic compounds
01/28/2010WO2008083054A3 Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure
01/28/2010US20100022782 Process for Preparing Fluoromethyl-Substituted Heterocyclic Compounds
01/28/2010US20100022780 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
01/28/2010US20100022611 1,5-Diaryl-Pyrazoles As Cannabinoid Receptor Neutral Antagonists Useful As Therapeutic Agents
01/28/2010US20100022605 N-hydroxyamide derivatives possessing antibacterial activity
01/28/2010US20100022570 Novel microbiocides
01/28/2010US20100022542 Compounds exhibiting thrombopoietin receptor agonism
01/28/2010CA2728629A1 Adamantyl diamide derivatives and uses of same
01/27/2010EP2146967A2 Tetrahydroindole and tetrahydroindazole derivatives
01/27/2010EP2146966A1 4-(3-amino benzoyl)-1-methylpyrazoles and the use thereof as herbicides
01/27/2010EP2146965A1 4-(3-amino benzoyl)-1,3-dimethylpyrazoles and the use thereof as herbicides
01/27/2010EP2146963A2 Dual-acting antihypertensive agents
01/27/2010EP1893581B1 Substituted arylpyrazoles for use against parasitites
01/27/2010EP1656353B1 Gabanergic modulators
01/27/2010CN101636389A Heterocyclyl-substituted-tetrahydro-naphthalen derivatives as 5-ht7 receptor ligands
01/27/2010CN100584830C Gabanergic modulators
01/26/2010US7652149 Crystalline pyrazoles
01/26/2010US7652057 Pyrazolones as 11b-HSD1 inhibitors for diabetes
01/26/2010US7652052 Process for producing ramosetron or its salt
01/26/2010US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus
01/26/2010US7651539 Dye composition of acidic pH comprising 2,3-diamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one, a coupler, a particular surfactant and an oxidizing agent and processes and kits using said composition
01/26/2010US7651537 Composition for dyeing keratin fibers, comprising 2,3-diamino-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazol-1-one, 6-chloro-2-methyl-5-aminophenol and a substituted meta-aminophenol
01/26/2010US7651536 Strong, chromatic, aesthetic, and/or sparingly selective coloring; visible deep red shades which shows good resistance to thevarious attacking factors to which the hair may be subjected, such as shampoo, light, sweat, and/or permanent waves; dyeing grey/white hair
01/26/2010CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
01/21/2010WO2010009290A1 Alpha7 nicotinic acetylcholine receptor inhibitors
01/21/2010WO2010008081A1 Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter
01/21/2010WO2010007046A2 Organic compounds
01/21/2010WO2010006945A1 Substituted indolyl and indazolyl derivatives and uses thereof
01/21/2010WO2010006944A1 Aminotetrahydroindazoloacetic acids
01/21/2010WO2010006939A1 Aminotetrahydroindazoloacetic acids
01/21/2010WO2010006485A1 Benzoxazinopyrazoles and their ring-opening compound
01/21/2010WO2009135808A3 Method for preparing 1,3,4-substituted pyrazol compounds
01/21/2010WO2009000442A8 Processes for the preparation of pyrazoles
01/21/2010US20100016612 Fluorine-containing pyrazolecarbonitrile derivative and method for producing the same, and fluorine-containing pyrazolecarboxylic acid derivative obtained by using the fluorine-containing pyrazolecarbonitrile derivative and method for producing the same
01/21/2010US20100016611 Methods for making central nervous system agents that are trpv1 antagonists
01/21/2010US20100016397 Pyrrole and Pyrazole DAAO Inhibitors
01/21/2010US20100016396 Pyrazole compound
01/21/2010US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties
01/21/2010US20100016369 Aminotetrahydroindazoloacetic acids
01/21/2010US20100016368 Aminotetrahydroindazoloacetic acids
01/21/2010US20100016331 Novel compounds
01/21/2010US20100016320 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
01/21/2010US20100016308 Tetrahydroindole Derivatives for Treatment of Alzheimer's Disease
01/21/2010US20100016233 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
01/21/2010US20100015093 Methods and compositions of treating a flaviviridae family viral infection
01/21/2010CA2731097A1 Organic compounds
01/21/2010CA2730397A1 Substituted indolyl and indazolyl derivatives and uses thereof
01/21/2010CA2730390A1 Aminotetrahydroindazoloacetic acids
01/21/2010CA2729606A1 Alpha7 nicotinic acetylcholine receptor inhibitors
01/21/2010CA2728311A1 Aminotetrahydroindazoloacetic acids
01/20/2010EP1831159B1 Tetralin and indane derivatives and uses thereof
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 256